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ABSTRACT

Thrombocytes are the most abundant circulating cells next to red blood cells in avian
blood. Avian thrombocytes are homologous in function to mammalian platelets. Avian
thrombocytes and the mammalian platelet are widely recognized contributors to
inflammatory responses upon stimulation with various microbial stimulants. However,
some observed responses of the avian thrombocyte depart from a standardized model
ascribed to innate cells. To help unravel the role of thrombocytes in innate immunity, and
possibly adaptive immunity, first we examined the surface features of chicken
thrombocytes. Chicken thrombocytes constitutively express transcripts for different Tolllike receptors (TLRs) that are crucial for the innate immune response. We observed
surface expression of major histocompatibility complex II, which is exclusively limited to
true antigen presenting cells (APC). Furthermore, we have also detected surface
expression of co-stimulatory molecules CD40, 80 and 86 on chicken thrombocytes.
Expression of MHC II and co-stimulatory molecules indicates that thrombocytes are
unconventional/unique immune cells that not only resemble innate effector cells in
function but may have a role in affecting adaptive immunity through cellular contact and
interaction with APC and lymphocytes. Next, we examined inflammatory responses
when thrombocytes were stimulated in vitro and in vivo with several TLR ligands and
vaccines, respectively. In vitro treatment of thrombocytes with various TLR ligands
demonstrates a definite bacterial effect while no viral effect on gene expression of IL-6.
Bacterial ligand, LPS stimulation led to release of significant amounts of active IL-6 in
the thrombocyte culture supernatants. The in vitro treatment of thrombocytes also
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indicated constitutive expression of iNOS gene expression. Although in vitro treatment of
thrombocytes with viral TLR ligands induced significant release of nitric oxide (NO) into
culture supernatant, bacterial TLR ligands did not lead to release of NO. In vivo treatment
by vaccination with the recommended doses was not sufficient to stimulate chicken
thrombocytes to induce expression of pro-inflammatory mediators. Understanding how
TLRs initiate particular thrombocytic responses and the involvement of thrombocytes in
antigen presentation may shed new light on adjuvant and vaccine research for vaccine
development for different poultry diseases.
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CHAPTER I
LITERATURE REVIEW

1.1 Overview
Among all the cells in the blood vascular system, platelets in mammals and
thrombocytes in lower vertebrates such as birds, reptiles, amphibians and fish are the
source of crucial mediators in hemostatic functions. Although, these cells have been
known to be primarily involved in thrombosis and hemostasis; platelets and thrombocytes
have been shown recently to have a role in inflammatory functions and the immune
response in general. Here, we discuss the thrombocyte of the avian immune system and
its role in the immune response. We start by discussing the unique features of the avian
immune system and the cells involved in innate and adaptive immunity, which will lead
to a description of the origin, structure and function of thrombocytes/platelets.

1.2 Avian Immune System
The avian immune system functions in general as the mammalian immune system.
The immune responses can be divided into two types: innate and adaptive. Innate
immunity is less specific and it provides the first line of defense against infection while
adaptive immunity is more specific and long term against an invading pathogen. There
are some differences in the avian and the mammalian immune systems and in the ways
each develops and becomes diverse enough to meet lifelong challenges. Below we
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present some of these major differences and later discuss the avian innate and adaptive
responses.
The most significant structural difference is in the lymphoid organs of the avian
immune system. A primary lymphoid organ is where lymphocytes first express antigen
receptors, gain phenotypic and functional maturity. The bursa of Fabricius is a
specialized primary lymphoid organ involved in B-cell development of birds (Glick et al.,
1956; Sharma, 1991 and 1997; Ola´h et al., 2014). The thymus is another primary
lymphoid organ that is present in both birds and mammals. However, the mammalian
thymus has only two lobes (Kindt et al., 2007) while the avian thymus consists of 7-8
lobes along each side of the neck (Ola´h et al., 2014) indicative of distinctly different
embryological origins. T-cell differentiation takes place in the thymus (both species)
while B-cell differentiation occurs in bursa of Fabricius (aves) or bone marrow
(mammals). A secondary lymphoid organ is usually where lymphocytes encounter
antigen, become activated, and undergo clonal expansion and differentiation into effector
cells. In mammals, highly organized secondary lymphoid organs include lymph nodes,
and spleen, while less organized lymphoid tissue known as mucosa-associated lymphoid
tissue (MALT) includes Peyer’s patches, tonsils, and the appendix (Kindt et al., 2007).
Although chickens lack defined lymph nodes, these birds have spleen and all mucosaassociated tissues, such as the occular associated lymphoid tissue (the Harderian gland
and the conjunctiva of the lower eyelid), the nasal-, bronchus-, genital- and gutassociated lymphoid tissues (esophageal and pyloric tonsils, Peyer’s patches, cecal tonsils

2

and Meckel’s diverticulum), and the skin and pineal-associated lymphoid tissues (Ola´h
et al., 2014).
Another unique aspect of the avian immune system is that the immunoglobulin (Ig)
diversity in birds is generated by somatic gene conversion events in which sequences
derived from upstream families of pseudogenes replace homologous sequences in unique
and functionally rearranged immunoglobulin heavy and light chain variable region genes
(Reynaud et al., 1985; McCormack et al., 1991; Ratcliffe, 2006; Fellah et al., 2014). In
humans and mice, the primary repertoire of Ig genes is created by combinatorial and
junctional variations that occur during the gene rearrangement events to produce
complete heavy and light chain Ig genes (Tonegawa, 1981; Kindt et al., 2007; Fellah et
al., 2014). This process mostly occurs in the bone marrow in humans and mice. Chicks
are born with an incomplete immune system and maternal immunity is passed on to
chicks when the embryo swallows amniotic fluid during hatch and in the absorption of
the egg yolk after hatch. Chicken Ig gene rearrangement occurs only during a brief period
of embryonic development and gene conversion takes place in the bursal
microenvironment (Ratcliffe, 2006; Fellah et al., 2014) from 15-17 days of incubation
until bursa of Fabricius involution at sexual maturity.

1.2.1 Innate Immune Response
In the mammalian and avian systems, the non-specific immune response includes
the innate or inherent ways each resists disease. Although there are differences in some of
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the effector cells or molecules that are produced, the general mechanisms involved in the
innate immune response in both birds and mammals are very similar. The cells of the
innate immune system have or produce molecules such as defensins, cytokines, and
chemokines for effector function upon pathogen recognition. Defensins are small,
cationic, natural anti-microbial peptides. These generally bind to microbial cell
membranes and form pores which directly lead to microbial cell death and
chemoattraction of innate effector cells to help kill the microbe (Soruri et al., 2007).
Cytokines are essentially molecular messengers that control and coordinate immune cells
both during innate and adaptive immune responses, as well as during development and
homeostasis (Kaiser, 2010). In the innate response, these molecules drive inflammatory
responses and the acute phase response.
Cells associated with the non-specific, innate immune response include
phagocytic cells, natural killer (NK) cells, basophils, and mast cells. The primary
function of a phagocytic cell is to engulf and destroy pathogens upon identification.
Common phagocytes are monocyte/macrophages and neutrophils in mammals or
heterophils in birds (chicken). In recent years, researchers have shown that platelets
(Clawson and White, 1971; Klinger, 1997; Klinger and Jelkmann, 2002; Elzey et al.,
2003) or thrombocytes (Glick et al., 1964; Carlson et al., 1968; Ferdous et al., 2008;
Hitchcock, 2009; Scott and Owens, 2008; Paul et al., 2012) are also involved in innate
immunity and inflammation.
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Table 1.1 Avian Toll-like receptors (TLRs) and their ligands.

(Adapted from Brownlee and Allan, 2011)
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Table 1.2. Different pathogen recognition receptors (PRRs ) present in human and
chicken.

(Adapted from Kaiser, 2010)
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The innate immune system provides an important initial response against
pathogens to limit or prevent infection. Most components of innate immunity are present
before the onset of infection and constitute a set of disease-resistance mechanisms that
include cellular and molecular components to recognize classes of molecules on a
particular pathogen and some endogenous proteins. The innate effector cells are activated
through pathogen recognition receptors (PRRs), which play a major role in initiating the
innate immune response by recognizing exogenous and endogenous antigens (Akira et
al., 2001; Akira and Takeda, 2004). These cells identify pathogen-associated molecular
patterns (PAMPs), which include combinations of sugars, certain proteins, particular
lipid-bearing molecules, and some nucleic acid motifs expressed on the surfaces of
pathogens. Toll-like receptors (TLRs) are some of the best characterized membranebound PRRs. Table 1.1 presents a list of avian TLRs and the ligands that activate through
these PRRs (Brownlie and Allan, 2011). There are also specific cytoplasmic PRRs in
both avian and mammalian systems such as nucleotide-binding oligomerization domain
(NOD) like receptors (NLRs) and RNA helicases (Table 1.2 adapted from Kaiser, 2010).
Innate effector cells perform phagocytosis and killing of microbes by producing
antimicrobial peptides, and other effector molecules such as reactive oxygen and nitrogen
species. These cells are also involved in inflammatory responses, which include localized
and systemic effects in response to tissue injury and other trauma. Tissue injury causes
release of vasoactive and chemotactic factors that initiate a local increase in blood flow
and capillary permeability. Increased capillary permeability allows an influx of
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antimicrobial exudate and phagocytes to the sites of infection in order to destroy and
remove foreign pathogens and heal damaged tissue.
In addition, the activation of the innate immune response can be a prerequisite for
the triggering of acquired immunity and in some ways determines the course of an
adaptive immune response. Through the recognition of pathogens or their products, the
PRRs like TLRs can induce the production of cytokines such as IL-12 and IL-18 in
antigen presenting cells (APCs), which function as "instructive" cytokines and drive
naïve T- cells to differentiate into T-helper cell type 1 (TH1) cells (Fig. 1.1).

1.2.2 Adaptive Immune Response
The specific immune responses include adaptive or acquired immunity characterized
by specificity, heterogeneity, and memory. T and B cells are major effector cells in both
avian and mammalian adaptive immune responses. Intracellular pathogens are generally
cleared by cell-mediated adaptive immune responses initiated by recognition of antigens
by T cells. Antigen presenting cells (APCs) play an important role in the innate immune
response and linking the innate and adaptive immune response by activating naïve T-cells
leading to proliferation and differentiation of effector and memory T-cells (Fig. 1.1).
Professional APCs include dendritic cells (DCs), macrophages and B cells. These cells
acquire microbial components during the innate response by phagocytosis, endocytosis or
other similar processes. In humans, DCs bring microbial components from the site of
infection to lymph nodes. In the lymph nodes, microbial antigens that are displayed on
the major histocompatibility complex (MHC) of DCs are presented to T cells resulting in
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Figure 1.1: Regulation of T-helper cell development by Toll-like receptors (TLRs)
on antigen presenting cells (APCs). Through recognition of pathogens or their products,
TLRs can induce the production of cytokines in APCs. Pathogens are captured in
multiple ways, including phagocytosis, endocytosis or via TLRs themselves. Captured
pathogens are processed and presented to T-cells as major histocompatibility complexantigen. For expansion of antigen-specific T cell clones, antigen presentation requires upregulated expression of costimulatory molecules on the cell surface of APCs which can
be triggered by TLR signaling (Adpated from Akira et al., 2001).

9

T-cell activation. Extracellular pathogens are usually cleared by humoral immune
responses mediated by antibodies produced by B cells and plasma cells. Antigen specific
protection against various pathogens can also be achieved by passive immunity, which
consists of maternal antibodies that are present at hatch in chicks. Recently, researchers
have recognized the role of mammalian platelets in the adaptive immune response (Henn
et al., 1998; Elzey et al., 2003; Elzey et al., 2005). Platelets have been shown to influence
DCs and thereby modulate T-cell responses. The role of avian thrombocytes in the
adaptive immune system is a relatively new area of research (Tregaskes et al., 2005; Paul
et al., 2012). Before we discuss the physiological role of thrombocytes or platelets,
including the role in innate and adaptive immune responses, we will discuss
thrombocytes/platelets in more details.

1.3 Thrombocytes/ Platelets
Thrombocytes/platelets are small, circulating, and the most abundant cells next to
erythrocytes in blood. Although thrombocytes and platelets are homologous in function,
there are some differences in their origin and morphology. Enucleated platelets are only
found in mammals while nucleated thrombocytes are found in lower vertebrates such as
reptiles, amphibians, fish and birds (Levin 2007). Invertebrate species have circulating
nucleated cells in their hemolymph termed hemocytes that are similar in function to
thrombocytes/platelets (Levin, 2007). Below we discuss thrombocytes in lower
vertebrates, birds and mammals in more detail.
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1.3.1

Thrombocytes in Lower Vertebrates
Historical studies of thrombocytes in lower vertebrates are focused on

characterization of morphological features and the role of thrombocytes in hemostasis
(Desser and Weller, 1979; Daimon et al., 1987; Daimon et al., 1979a; Daimon et al.,
1979b; Daimon and Uchida, 1985; Jagadeeswaran, et al., 1999; Rey Vázquez and
Guerrero, 2007). Lower vertebrate thrombocytes are, like those of higher vertebrates and
platelets, the most abundant blood cells after erythrocytes (Meseguer et al., 2002). The
process of thrombopoiesis takes place in different tissues in adult animals, depending on
the vertebrate group and species. Thrombopoiesis consists of immature and mature
prothrombocytes and thrombocyte cell stages prior to the formation of the circulating
thrombocyte (Esteban et al., 1989). According to a review by Meseguer et al. (2002),
thrombopoiesis occurs in the lymphomyeloid and lymphoid tissues in fish (Esteban et al.,
1989; Zapata et al., 1996), the spleen, kidney, liver, and more rarely bone marrow in
amphibians (Welsch and Storch, 1982; Zapata et al., 1982), and the bone marrow or
spleen in reptiles (Rowley et al., 1988). Below we discuss the structure of fish
thrombocytes.
Circulating thrombocytes in fish are similar in size to lymphocytes and appear as
round, oval, spindle, or spiked cells with long cell processes (Daimon et al., 1979b;
Daimon and Uchida, 1985; Jagadeeswaran, et al., 1999; Rey Vázquez and Guerrero,
2007; Esteban et al., 2000). The cytoplasm of fish thrombocytes contains numerous
vesicles that occasionally, open to the cell surface indicating the presence of a surface
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Figure 1.2: Electron micrographs of zebrafish thrombocyte. Zebrafish thrombocyte
with open canalicular-like system is shown by yellow arrowhead; N: nucleus (a). An
activated thrombocyte in an aggregation reaction; activated thrombocyte is shown by a
thick red arrow, thrombocyte in the aggregate shows filopodia shown by a thin red arrow;
E: erythrocyte (b) (Adpated from Jagadeeswaran et al., 1999).
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connected canalicular system (Fig. 1.2). Aggregates of thrombocytes with pseudopodialike projections are also observed in Figure 1.2. A marginal band of microtubules
maintains the shape of fish thrombocytes (Meseguer, 2002). Some mitochondria,
glycogen deposits, and a Golgi apparatus are also found in these cells.
In recent years, zebrafish is one of the species where thrombocytes have been
studied more extensively. Zebrafish thrombocytes are well characterized and several
functional assays have been established to study the hemostatic function of these cells
(Khandekar et al., 2012). The zebrafish thrombocyte has been suggested to be the
hemostatic homologue of the mammalian platelet due to combined morphologic,
immunologic and functional evidence and conservation of major hemostatic pathways
involved in platelet function and coagulation (Jagadeeswaran, et al., 1999). Several
researchers have demonstrated usefulness of zebrafish as a relatively more practical
vertebrate genetic model to study mammalian platelet function (Jagadeeswaran, et al.,
1997 and 1999; Khandekar et al., 2012; Thijs, et al., 2012).

1.3.2

Thrombocytes in Birds
Avian thrombocytes are the most abundant white blood cell type in chicken blood

(Change and Hamilton, 1979). In circulating chicken blood; the concentration of
thrombocytes is 3 x 104 cells/mm3 compared to only 5 x 103 cells/mm3 for heterophils
(Glick, 1958). These cells are round, oval or somewhat elongated with an irregular
outline (Lucaz and Jamroz, 1961; Hodges, 1979) and occasionally, there is presence of
fine pseudopodial processes (Fig. 1.3). The cytoplasm of the thrombocyte contains a few
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Figure 1.3: Electron micrographs of avian thrombocyte. The micrograph shows
normal thrombocyte (a), spread thrombocyte (b), thrombocyte decomposed and attached
to red blood cell resulting in red blood cell clumping is shown (c and d) ( Adapted from
Narkkong et al., 2010).
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Figure 1.4: Appearance of a typical blood smear of Single Comb White Leghorn
chicken It is showing red blood cells (black arrows), thrombocytes (red arrows),
heterophil (white arrow), and lymphocytes (blue arrows) (adapted from Lucas and
Jamroz, 1961).
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small mitochondria, smooth and rough endoplasmic reticulum, and often a welldeveloped Golgi apparatus. The average width and length of a mature avian (chicken)
thrombocyte is approximately 5 and 10 µm, respectively. Thrombocytes bear a
superficial resemblance in both shape and general appearance to red blood cells (RBCs)
in avian blood (Fig. 1.4). Thrombocyte cytoplasm also has microtubules at the outermost
zone of the cell and large vacuoles connected to the canalicular system or opened to the
surface. Morphologically these cells can be distinguished from monocytes and
lymphocytes by electron microscopy and in fresh preparations by phase microscopy.
Thrombocytes in peripheral blood of different avian species such as chicken, turkey and
Japanese quail are very similar in terms of the ultrastructure (Sweeny and Carlson, 1968;
Simpson, 1968; Nirmalan et al., 1972). Maxwell (1973) also compared thrombocytes in
six species of domestic bird (duck, geese, turkey, pigeon, quail and guinea-fowl) and
found little difference in terms of the ultrastructure, confirming that thrombocytes are
very similar in different avian species. Thrombocytes have the capacity to store a number
of intra-cellular secretory granules that can be released into the circulation or translocated
to the surface when activated. Avian thrombocytes are also capable of producing and
releasing a vast array of bioactive proteins. Presence of large, acid phosphatase-positive
granules has been observed histochemically in the cytoplasm of avian thrombocytes,
which may be similar to the lysosomal granules in mammalian platelets (Carlson et al.,
1968).
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Historically, there have been some conflicting views on the origin of avian
thrombocytes (Sugiyama, 1926). One group believes that thrombocytes are descendants
of lymphocytes or primitive lymphoid cells, while another group believes that these cells
are of endothelial origin. Some consider thrombocytes as damaged or degenerated red
blood cells (RBCs). Thrombocytes are often regarded as the antecedent of mononucleated
cells that have a blast stage like that of other blood cells (Lucaz and Hamroz, 1961).
According to Archer (1971), large cells in chicken bone marrow appear to be
multinucleated and could be the precursors of thrombocytes. More recent research shows
that thrombocytes originate from cells that resemble multipotent hematopoietic
progenitors and are produced in the region where earliest intraembryonic hematopoietic
cells develop (McNagny et al., 1997). Chicken thrombocytes usually become
morphologically distinguishable from erythrocytes on Day 3 of incubation (after 65 hr
incubation). However, presence of glycogen granules can be used as a thrombocyte
specific marker to detect immature thromboblasts as they first emerge after 35 hr of
incubation (Tahara et al., 1983). Thrombocytes express surface marker thrombomucin,
which is distantly related to CD34, a well-known human hematopoietic stem cell marker.
In addition to thrombomucin, receptor c-myeloproliferative leukemia virus oncogene
(Mpl) is also expressed on the surface of cells of the thrombocytic lineage (Bartunek et
al., 2008). Chicken thrombocytes can be identified with monoclonal antibodies such as
23C6 (Viertlboeck and Göbel, 2007) and K1 (Kaspers et al., 1993) that recognize the
intact complex formed between CD41 and CD61 (αV and β3 integrin) and an
unidentified epitope, respectively, on the surface of chicken thrombocytes.
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1.3.3

Mammalian Platelets
Mammalian platelets are enucleated, small oval disc shaped cells. Although

platelets lack a nucleus, these cells contain functional spliceosomes which are a multimegadalton ribonucleoprotein complex. Spliceosomes process pre-mRNAs in the
absence of nuclei during platelet formation from megakaryocytes. In addition, human
platelets also contain essential spliceosome factors including small nuclear RNAs,
splicing proteins, and endogenous pre-mRNAs; all the translational machinery necessary
to generate their own proteins during stimulatory events (Denis et al., 2005). A human
platelet is usually 2 - 4 µm in diameter and reported platelet counts range from 150 - 400
x 109 platelets per liter of blood (Yeaman, 1997; Klinger and Jelkmann, 2002; Semple et
al., 2011).
The platelet plasma membrane surface is generally smooth except for some
periodic invaginations that delineate the entrances to the open canalicular system (Fig.
1.5). Similar to avian thrombocytes, this complex network of intertwining membrane
tubes permeate the cytoplasm of platelets. Due to this system of folded membranes,
platelets have an enormous surface area. When platelets are activated, an influx of
calcium initiates the process of rapid change of shape from smooth discs to spiny spheres
with development of finger-like filopodia and pseudopods (Semple et al., 2011). The
cytoplasm of a platelet is rich in actin and myosin which provides the force for this
change in shape.

18

Figure 1.5: Electron micrographs of mammalian platelet. Here, top right part shows a
more spherical form of resting platelet compared to an activated one with long
pseudopodia (Adapted from George, 2000).
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Mammalian platelets have three major types of storage granules: (i) α-granules,
(ii) dense granules, and (iii) lysosomes (Yeaman, 1997; Semple et al., 2011). The
secretory granules found in avian thrombocytes are not as well characterized as
mammalian platelets. The α-granules are the most abundant granules in mammalian
platelets; and the granule protein content is derived by a combination of endocytosis and
biosynthesis. These granules are involved in secreting several different bioactive proteins
including coagulation factors, chemokines, adhesive proteins, mitogenic factors and
regulators of angiogenesis.
The production of platelets is a complex progression of events that results with a
single megakaryocyte releasing thousands of platelets into circulation. Platelets originate
from the megakaryocytes of the bone marrow. Megakaryocytes produce platelets by
rearranging the cytoplasm into long extensions called proplatelets that resemble strings of
beads. The process of platelet morphogenesis takes place in platelet-rich plasma where
megakaryocyte processes first elongate, then bead and fragment, and then curve and fuse
to form disk-shaped platelets (Behnke and Forer, 1998; George, 2000). Thrombopoietin
is the major hormone controlling megakaryocyte development and thus is the regulator of
platelet production (George, 2000).

1.4 Physiological Role of Thrombocytes/Platelets
Although

there

are

some

differences

in

the

origin

and

structure

of

thrombocytes/platelets in different species, these cells are very similar in their function.
There has been a lot more research done with mammalian platelets, so the role of these
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cells in physiological function, and capability to be involved in the immune response, is
better understood compared to thrombocytes. Below we discuss the major physiological
functions of platelets and thrombocytes.

1.4.1

Hemostasis
The primary physiological role of the mammalian platelet as well as the avian

thrombocyte is to sense damaged vessel endothelium and accumulate at the site of the
vessel injury, where these cells initiate blood clotting to block the circulatory leak.
However, the rate at which clumping takes place in the avian thrombocyte is much
slower compared to that of mammalian platelets (Hodges, 1979). The dense granules in
platelets secrete adenosine diphosphate (ADP) and calcium, which are associated with
platelet aggregation and platelet surface coagulation reactions. Avian thrombocytes do
not aggregate by ADP or adenosine triphosphate (ATP) release; however thrombocytes
can undergo aggregation when a micromolar concentration of serotonin is secreted from
intra-cellular granules (Belamarich and Simoneit, 1973). In addition to forming an
aggregate, activated platelets favor thrombin and fibrin formation.

1.4.2

Inflammation
After tissue injury, platelets take part in the process of inflammation following the

hemostatic process and thrombus formation. Proteomic analysis has demonstrated that
thrombin activated platelets can secrete more than 300 different proteins including proinflammatory cytokines, chemokines, and cell adhesive proteins (Weyrich and
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Table 1.3: List of inflammatory, antimicrobial and immune modulating molecules
released by activated human platelets.

(Adapted from Semple et al., 2011)
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Zimmerman, 2004; Semple et al., 2011). Table 1.3 lists some of the platelet-associated
molecules, immune functions and cellular targets of those molecules. For example,
activated platelets (human) are associated with mediating the adhesion of neutrophils and
dendritic cells to the site of tissue injury and also up-regulating the release of proinflammatory cytokines and chemokines. Avian thrombocytes are also able to release a
variety of similar bioactive compounds; chemotactic factors (e.g. Macrophage
Inflammatory Protein-1β), other mediators in inflammation such as Cyclooxygenase-2
(COX-2), and prostaglandin D2 (PGD2), PGE2, thromboxane A2 synthases and
leukotriene B4 (Lam, 2002; Scott and Owens, 2008; Hitchcock, 2009; Jha et al., 2005).
Chicken thrombocytes express transcripts of anti-inflammatory cytokines transforming
growth factor (TGF)-β and interleukin (IL)-10 (Paul et al., 2012) and up-regulate
expression of pro-inflammatory cytokines (IL-1β, IL-6, IL-8 and IL-12) when stimulated
with LPS (Ferdous et al., 2008; Hitchcock, 2009; Scott and Owens, 2008).

1.4.3

Wound Healing
In addition to forming an aggregate and taking part in the process of

inflammation, mammalian platelets express and release proteins and substances that
promote tissue repair. The binding of secreted proteins within a developing fibrin mesh or
to the extracellular matrix can create chemotactic gradients favoring the recruitment of
stem cells, stimulating cell migration and differentiation, and promoting repair (Semple et
al., 2011). Chicken thrombocytes have been shown to have transcripts for plateletderived growth factors (Horiuchi et al., 2001; Horiuchi et al., 2002) that may have
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important roles in healing damaged tissue (Wachowicz and Krajewski, 1981; Horiuchi et
al., 1990).

1.4.4

Immunological Capacity
Although platelets and thrombocytes have been well recognized for their

importance in homeostasis and their contribution to wound healing, their role in antimicrobial host defense and immunity have been historically underappreciated. The role of
these cells in the immune response began with the evidence of their phagocytic ability,
followed by their role in the inflammatory response. More recently, the presence of germline encoded PRRs such as TLRs have led to a new understanding of the
platelet/thrombocyte role in immune responses. To date, the mammalian (human and
mice) platelets have been confirmed to express TLR1-9 and the avian (chicken)
thrombocytes express TLRs 2-5, 7 and 21. This characteristic strengthens the notion that
platelets may have direct roles in protecting the host from infection like any other
leukocytes. Figure 1.6 shows some examples of how activated platelets can affect the
innate immune response. In addition to their role in the innate immune response, these
cells have been shown recently to be associated with adaptive immunity.

1.4.4.1 Innate Immune Response
Although historically underappreciated for their role in anti-microbial host
defense, at present platelets are regarded as an integral part of inflammation and potent
effector cells of the innate immune response. Platelets are capable of binding,
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Figure 1.6: Activated platelets can mediate cell–cell interactions and affect immune
responses. Platelet Toll-like receptor (TLR) expression enables activated platelets to bind
and capture bacteria that may directly kill the bacteria by producing thrombocidins or by
aggregating around the bacteria and ‘trapping’ them for elimination by professional
phagocytes (a). Platelets can also interact with a wide variety of cells, including
leukocytes (b). Activated platelets can also promote the activation of monocytes and
DCs, particularly through CD40–CD154 (also known as CD40L) interactions (c)
(Adapted from Semple et al., 2011).
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aggregating, and internalizing microorganisms which enhances clearance of pathogens
from the bloodstream. For example, platelets can bind to Plasmodium chabaudi infected
red blood cells; induce intracellular parasite killing and cell destruction (Yeaman et al.,
1992). These cells have been shown also to actively bind circulating bacteria and
microbial products, and present those to neutrophils and cells of the reticuloendothelial
system (Aslam et al., 2006). Glick et al. (1964) first demonstrated the phagocytic ability
of circulating thrombocytes. Avian thrombocytes are capable of phagocytosing bacteria
(Glick et al., 1964; and Carlson et al., 1968), dye particles (Carlson et al., 1968), and
viruses (Hodges, 1979). Chang and Hamilton (1976) have suggested that thrombocytes
are the primary circulating phagocytes in the chicken. Thrombocytes phagocytized about
three times as rapidly as heterophils and monocytes (Chang and Hamilton, 1979a). Chang
and Hamilton (1979a) have shown also that circulating thrombocytes engulfed nearly
twice as many bacteria as the heterophil and monocyte together.

1.4.4.2 Adaptive Immune Response
The discovery of functional CD40 ligand (CD40L/CD154), a molecule of vital
importance to the adaptive immune response on the surface of activated platelets (Henn
et al., 1998), has led researchers to investigate the potential modulatory capacity of
platelets in bridging innate immunity to the adaptive side of immune responsiveness.
CD40 and CD40L are a receptor-ligand pair with a central role in promoting interactions
between lymphocytes and APCs such as DCs.
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DCs are known as the most important link between innate and adaptive immunity
since these cells are thought to be the only cells capable of activating naïve T-cells
sufficiently for induction of a productive cellular immune response. Initially, platelets
have been shown to activate DCs in vitro and promote T-cell responses via CD40L.
Later, platelet-derived CD40L has been shown to augment CD8+ T-cell responses, both
in vitro and in vivo, and to promote protective T-cell responses following infection with
Listeria monocytogenes (Elzey et al., 2008). Platelets can also modulate T-cell responses
through non-CD40L dependent mechanisms. In a hepatitis model, platelet depletion has
been shown to prevent cytotoxic T-lymphocytes entry into the liver, which protects
against acute organ damage (Iannacone et al., 2005). Platelet-derived CD40L has been
reported to support B-cell differentiation and immunoglobulin class-switching in mice
(Elzey et al., 2003). During viral infections, transfer of wild-type platelets to CD40L
mutant mice has been shown to transiently increase production of virus-specific IgG and
protect the animals from subsequent viral infection (Elzey et al., 2003). This
phenomenon suggests that platelet-derived CD40L has the ability to promote protective
adaptive immune responses. CD40L expressed on the surface of platelets can also
interact with CD40 on endothelial cells to induce endothelial cell up-regulation of several
adhesion molecules such as intercellular adhesion molecule 1 (ICAM1) and vascular cell
adhesion molecule 1 (VCAM1) and release of CC-chemokine ligand 2 (CCL2) (Andre et
al., 2002). All of which promote leukocyte recruitment to inflammatory sites. Activated
platelets also release soluble CD40L. Soluble CD40L can interact with vascular
endothelial cells and induce the up-regulation of E-selectin and P-selectin and the release
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of pro-inflammatory cytokines, IL-6 and other tissue factors (Hammwöhner, et al., 2007
and Anand et al., 2003).
Avian thrombocytes also express CD40L among other biologically active surface
molecules and receptors (Tregaskes et al., 2005). Similar to mammalian platelets, the
discovery of functional CD40L is of vital importance in the potential modulatory capacity
of thrombocytes in bridging innate immunity to the adaptive side of immune
responsiveness. Thrombocytes are more than innate effector cells. In addition to CD40L,
a recent article indicates that chicken thrombocytes also express transcripts for CD40,
CD80 and MHC II (Paul et al., 2012). Therefore, chicken thrombocytes should have not
only the ability to interact with APC but also have the potential to be involved in antigen
presentation. Besides expressing functional CD40L, platelets and thrombocytes can also
release cytokines such as IL-12 during activation by LPS (Ferdous et al., 2008).
Cytokines such as IL-12 are expressed by APCs that drive naïve T-cells to differentiate
into TH1 cells. Therefore, in addition to attracting APCs, platelets may be able to function
like non-professional APCs.

1.5 Impact/Relevance
The complete role of thrombocytes in the physiology of the chicken immune
system is still unknown. Thrombocytes are the most abundant white blood cells in avian
blood and there are almost six times more thrombocytes than heterophils in avian
circulation (Glick 1958; Lucas and Jamroz, 1961). It has been widely believed that other
innate effector cells such as heterophils play the most dominant role in the avian innate
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immune system (Kogut et al., 2002; Kogut et al., 2005). However due to the sheer
number and the above discussion regarding the role of thrombocytes as innate effector
cells, thrombocytes have the potential to play the role of a primary effector cell in the
immune system. In addition these cells may have a significant role in shaping the
adaptive immune response, as well.
The research reported herein enables us to better understand which pathogenic
ligands are recognized by chicken thrombocyte TLRs to initiate immune responses. It
may also assist in understanding involvement of chicken thrombocytes during various
microbial infections. Thrombocytes have recently been shown to have the potential to be
involved in antigen presentation and to interact with professional antigen presenting cells
such as DCs. Understanding how TLRs initiate particular immune responses and the
involvement of thrombocytes in antigen presentation may be applied to adjuvant and
vaccine research for improved vaccines for different poultry diseases.
Most vaccines require a vaccine adjuvant in order to get the immune system to
elicit an appropriate response. Since individual subsets of APCs often express different
TLRs, it may be possible to elicit specific immune responses by selectively targeted
antigen-TLR ligand fusion proteins to specific APC subsets (O’Neill et al., 2009). For
example, some lipid A analogues, agonists for TLR4 and CpG DNA, an agonist of TLR9
are being investigated for use as vaccine adjuvants (Romagne, 2007; Connolly and
O’Neill, 2012). In mammalian models, DCs can be potent inducers of T-cell-mediated
immunity and are activated through TLR ligation (O’Neill et al., 2009). TLR3 agonists
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such as Poly (I:C) have been demonstrated to have potential for DC-targeted vaccine
efficacy (O’Neill et al., 2009; Jurk and Vollmer, 2007). Thererfore, there is a need for
further research in this area to understand the potential interaction of thrombocytes with
other immune cells and understand the role of the thrombocytes in antigen presentation
for future adjuvant and thrombocyte-targeted vaccine research.
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CHAPTER II
DECIPHERING THE ROLE OF CHICKEN THROMBOCYTES IN IMMUNITY.

2.1 Introduction
Chicken thrombocytes represent the most abundant white blood cell type in chicken
blood (Chang and Hamilton, 1979) and are homologous in function to enucleated
mammalian platelets. Platelets and thrombocytes have been well recognized for
importance in homeostasis and contribution to wound healing, however, the role of these
cells in anti-microbial host defense and the immune system has been historically
underappreciated.
One of the early studies by Glick et al. (1964) demonstrates that thrombocytes have a
considerable role in antimicrobial host defense by displaying a phagocytic nature. More
recently, chicken thrombocytes have been shown to release a variety of bioactive
compounds such as pro- and anti-inflammatory cytokines, chemotactic factors, and other
mediators in inflammation (Ferdous et al., 2008; Scott and Owens, 2008; Hitchcock,
2009; Paul et al., 2012; Lam, 2002; Jha et al., 2005). The discovery of germ-line encoded
pattern recognition receptors (PRRs) such as Toll-like Receptors (TLRs) 2-5, 7 and 21 on
chicken thrombocytes adds to understanding the role of thrombocytes in the innate
immune response (Scott and Owens, 2008; Paul et al., 2012).
To help unravel the role of thrombocytes in innate immunity, and possibly adaptive
immunity, here we examine the immune capacity surface features of chicken
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thrombocytes. We focus especially on features that are shared with other immune cells;
especially the MQ.NCSU chicken macrophage cell line. In doing so, the broader
involvement of the thrombocyte in immunity of the chicken is explored.

2.2 Materials and Methods
2.2.1

Chickens
Female Single Comb White Leghorn (SCWL) chickens (between 16-24 weeks

old) were used for this study. The chickens were housed at the Clemson University
Morgan Poultry Center, Clemson, SC, which is an Institutional Animal Care and Use
Committee (IACUC) approved animal facility operating under standard management
practice adhering to the Association for Assessment and Accreditation of Laboratory
Animal Care International criteria.

2.2.2

Thrombocyte Isolation
Syringes fitted with needles were used to collect 3 mL of whole blood from the

wing vein of each chicken into 0.1 mL volume of 10% ethylene diamine tetra acetic acid
(EDTA) solution. The collected blood samples were stored on ice until brought back to
the laboratory. The thrombocyte isolation protocol has been modified from that used by
Horiuchi et al. (2004). Each blood sample was diluted (1:1) with calcium and magnesium
free Hanks balanced salt solution (HBSS) (Cambrex Bio Sciences Walkersville Inc.,
Walkersville, MD). Diluted blood samples were then layered on a lymphocyte separation
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medium (Density 1.077-1.080 g/mL, Mediatech. Inc., Herdon, VA) and centrifuged at
1700 x g for 30 min at 23°C. The resultant band of cells containing the thrombocytes was
collected, washed and resuspended in calcium and magnesium free HBSS. Trypan blue
solution (0.4% w/v in normal saline) was used for quantification of viable cell numbers
on a SPolite® Hemacytometer (Baxter Healthcare, McGaw Park, IL) with the aid of an
upright light microscope. An additional assessment of viability of thrombocytes was
determined with glass adhered cells used for microscopy studies. Isolated thrombocytes
(5 x 105 cells per 500µL) were incubated with fluorescent vital stain, calcein AM (1 µM,
Invitrogen) at 41°C and 5% CO2 for 30 minutes in a 4-chambered coverglass system #1.0
(Labtek). After washing, the chambers were then imaged in differential interference
contrast and green fluoresce using a Nikon Ti microscope with 60x APO water emulsion
objective (Clemson Light Imaging Facility, Clemson University, Clemson, SC).

2.2.3

MQ.NCSU Cell Culture
The MQ.NCSU cell line was a generous donation from Dr. Matthew Koci’s

laboratory (NCSU Prestage Department of Poultry Science, North Carolina State
University, Raleigh, NC). These cells were cultured at 41°C and 5% CO2 with LM Hahn
medium made with a combination of Lebovitz A medium (Sigma-Aldrich, St Louis, MO)
and McCoy’s 5a medium (Invitrogen Life Technologies), tryptose phosphate broth
(Sigma Aldrich, St Louis, MO), bovine fetal serum (HyClone®, Logan, Utah), chicken
serum (Sigma-Aldrich, St Louis, MO), glutamine, sodium pyruvate (CellGro, Mediatech
Inc, Manassas, VA), 2-mercaptoethanol (Sigma-Aldrich, St Louis, MO), and a mixture of
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penicillin, streptomycin, and fungizone (Lonza Walkersville Inc., Walkersville, MD)
(Qureshi et al., 1990).

2.2.4

Thrombocyte and MQ.NCSU Stimulation
The isolated thrombocytes or cultured MQ.NCSU cells (1 x 107 in 1 mL) were

incubated with 1 μg/mL of ultra-pure Lipopolysaccharide (LPS) from Salmonella
minnesota (TLR4 ligand) or 400 µg/mL of Polyinosinic-polycytidylic acid [Poly (I:C)], a
synthetic analog of double-stranded RNA (TLR3 ligand) (InvivoGen, San Diego, CA).
The cell suspension and TLR ligands were incubated in sterile 1.5 mL microcentrifuge
tubes on a rocking platform (VWR, Suwanee, GA) at 41°C for 10 and 60 min.

2.2.5

Antibodies
The monoclonal antibodies used to label cells include mouse anti-chicken

CD41/61 (MCA2240), CD40 (MCA2836), CD80 (MCA2837), CD86 (MCA2838), and a
MHC class II monomorphic (MCA2171) from BioRad AbD Serotec Inc., Raleigh NC.
Alexa Fluor® 488 F(ab’)2 fragment of goat anti-mouse Ig (H+L) (A11017) and Alexa
Fluor® 594 of goat anti-mouse Ig (H+L) (A11005) from Molecular Probes by Life
Technologies™, Grand Island, NY were used as the secondary antibodies. All primary
antibodies were used at a dilution of 1:200 while the secondary antibodies were used at a
dilution of 1:400.
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2.2.6

Fluorescent Microscopy
For fluorescent microscopy, slides were prepared by thrombocyte adherence. Cell

suspensions (200 µl) containing 2 x 106 cells were allowed to adhere to glass slides for 30
min at 41°C. Adhered thrombocytes were then fixed with 4% paraformaldehyde.
Monoclonal mouse anti-chicken CD41/61 at 1:200 dilution per 1 x 106 cells was used as
primary antibody with Alexa® 594 goat anti-mouse Ig (H+L) at 1:400 dilution per 2 x
106 cells as secondary antibody. The thrombocytes were counterstained with 4', 6diamidino-2-phenylindole (DAPI), at a dilution of 1:2000 per 2 x 106 cells. DAPI
preferentially stains double-stranded DNA of the cellular nuclei. For all washes and
dilutions of antibodies, HBSS containing 1% BSA was used unless otherwise stated.

2.2.7

Cytometry
For flow cytometry, 1 x 107 cells per microcentrifuge tube were used.

Thrombocytes were fixed with 1% paraformaldehyde overnight, and washed before a 15
min treatment with 0.1% Triton x-100 in HBSS. The washes were completed at 16,060 x
g for 3 min in a table top centrifuge. Next, a blocking step was performed by adding 10%
goat serum in HBSS at room temperature for 60 min. Finally, the cells were incubated
with mouse anti-chicken primary antibodies for CD41/61, CD40, CD80, CD86 or MHC
II and secondary antibody, Alexa 488, respectively. Labeled samples were evaluated
using a Beckman Coulter CyAn flow cytometer (Beckman Coulter, Inc., Brea, CA)
located at the CTEGD Flow Cytometry Core Facility, University of Georgia (UGA),
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Athens, GA. The results were analyzed with FlowJo Software at UGA and the Clemson
Light Imaging Facility (CLIF, Clemson University, SC).
For image-based cytometer, each cell suspension was stained in the same way as
described above for flow cytometry. The primary antibody used here was mouse antichicken CD41/61 and the secondary antibody was Alexa Fluor® 594 goat anti-mouse Ig
(H+L). Aliquots of 25 µL of the cell suspension (stained and unstained samples) were
placed on the specific Tali™ cellular analysis slides (Life Technologies™, Grand Island,
NY) for imaging. Images were analyzed using Tali™, an image based cytometer (Life
Technologies™, Grand Island, NY) available at the CLIF, Clemson University, SC.

2.2.8

RNA Isolation and Quantification
For RNA isolation after thrombocyte stimulation, cells were centrifuged at 5000 x

g for 2 min to pellet. The pellets were stored in 100 μL of RNAlater (Qiagen Inc.,
Valencia, CA), a RNA stabilizing solution. After 24 hr at 4°C in RNAlater, the cells were
centrifuged again to remove the supernatant. The cells can be stored at this point at -20°C
for use later if not used immediately. The RNeasy Kit (Qiagen Inc., Valencia, CA) was
used according to the manufacturer’s protocol to isolate the total RNA from these
samples. The RNA samples were treated with an on-column DNase, RNase-free DNase
Set (Qiagen Inc., Valencia, CA) to remove any possible contamination from chicken
genomic DNA. Isolated RNA samples were quantified using a Nano Drop 1000
Spectrophotometer (Thermo Scientific, Waltham, MA).
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2.2.9

Quantitative Real Time Polymerase Chain Reaction (qRT-PCR)
Quantitative RT-PCR was performed using a QuantiTech SYBR Green RT-PCR

Kit (Qiagen Inc., Valencia, CA) and an Eppendorf Mastercycler ep realplex (Eppendorf
North America, Westbury, NY). Primers used for GAPDH, TLR2, TLR3, TLR4 and
TLR7 amplification are listed in Table 2.1. The RT-PCR mixture consisted of 0.20 μL
QuantitTect RT Mix, 10 μL 2× QuantitTect SYBR Green RT-PCR Master Mix, 0.4 μL of
0.5 μM of each specific primer listed in Table 2.1, 8 μL of 1 ng/μL template RNA, and 1
μL of RNase-free water to make the final reaction volume of 20 μL. The cycling profile
for all the reactions was 1 cycle of 50°C for 30 min, 95°C for 15 min, and 40 cycles of
94°C for 15 s, 57°C for 20 s, and 72°C for 20 s.

2.2.10 Data Analysis
The data obtained from the qRT-PCR were analyzed using information on the cycle
number (Ct values). The software determined the cycle number for each sample at which
the fluorescence crosses the established threshold; this crossing point is referred as the Ct
value. The sample that expresses more of a given gene product has a lower Ct value while
the lower expressing sample has a higher Ct value. Relative quantification of mRNA
levels has been determined through the use of the relative fold change calculation
according to Pfaffl (2001). The amplification efficiencies (E) of target and housekeeping
genes are required to be approximately equal to one another for this method of relative
quantification (Table 2.1).
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Table 2.1: Quantitative real-time polymerase chain reaction primer sets for
messenger

RNA

of

glyceraldehyde

3-phosphate

dehydrogenase

(GAPDH,

housekeeping gene) and Toll-like receptors (TLRs) 2, 3, 4, and 7 of chickens.
Target

Accession No.

Primer Sequence (5’-3’)

RNA
GAPDH

Efficiency
(E)

NM_204305

F: ATGCCATCACAGCCACACAGAAGA

0.98

R: ATGCCATCACAGCCACACAGAAGA
TLR2

NM_001161650 F: AGAACGACTCCAACTGGGTGGAAA 1.03
R: AGAGCGTCTTGTGGCTCTTCTCAA

TLR3

NM_001011691 F: GCATTGCTTGGTTTGCTAGTTGGC

0.95

R: TGTCCTTGCAGGCTGAGGTATCAA
TLR4

NM_001030693 F: AGGGTTCCACCAGCTCTTTCATCA

1.02

R: AAGATGGGTGGTGTGTAGAAGCCT
TLR7

NM_001011688 F: ATCTGACGGTGTTGGATCTTGGGA
R: ACGTGCCTGCTGTATTGCTCTACT
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1.00

2.3 Results
2.3.1

Thrombocyte Validation

First we performed a viability assay with calcein AM in order to verify that thrombocytes
adhered to glass slides were still viable. The staining method verifies green viable
thrombocytes following glass adherence (Fig. 2.1). To determine if the isolated cells are
an enriched population of thrombocytes, cells were stained with an antibody for a
thrombocyte specific marker, CD41/61 (Fig. 2.2) and were visible through redfluorescent Alexa® 594 (Fig. 2.2A). Chicken thrombocytes that are adhered to glass
slides are shown as a monochromatic image in differential interference contrast, DIC
(Fig. 2.2C) and these cells appear to be small, circular in shape with rough edges. Upon
visual examination of a combined image, which is an overlay of blue (DAPI) and red
labeled cells on the DIC image, most of the cells appear to be thrombocytes (Fig. 2.2D).

Results from the image based cytometer, Tali™ show that the enriched cells are
on average 5 µm in diameter and 96% of those cells are positive for thrombocyte specific
marker CD41/61 (Fig. 2.3). Figure 2.3 also shows the red and green fluorescence and
other threshold values set for the cell analysis. Further analysis by flow cytometry shows,
expression of CD41/61 on chicken thrombocytes is not affected by stimulation with LPS
nor Poly (I:C). CD41/61 was positively expressed on more than 99% of control, LPS and
Poly (I:C) treated chicken thrombocytes (Fig. 2.4).
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Figure 2.1: Green fluorescent image of viable chicken thrombocytes. In order to
verify if thrombocytes adhered to glass slides were still viable, isolated thrombocytes (5 x
105 cells per 500µL) were incubated with fluorescent vital stain, calcein AM (1 µM,
Invitrogen). The cells visualized using the Nikon Ti microscope with 60x APO water
emulsion objective (Clemson Light Imaging Facility, Clemson University, Clemson, SC).
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Figure 2.2: Microscopy images of CD41/61 and 4',6-diamidino-2-phenylindole
(DAPI) stained chicken thrombocytes. Chicken thrombocytes visualized with (A.)
Alexa Fluor® 594 labeled monoclonal mouse anti-chicken CD41/61, a thrombocyte
specific marker, (B.) DAPI, a nuclear stain, and (C.) monochromatic differential
interference contrast (DIC). The last image is a combined image showing all of the above
(D.). The cells were visualized using the Nikon Ti microscope with 60x APO water
emulsion objective (Clemson Light Imaging Facility, Clemson University, Clemson, SC).

D
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Figure 2.3: Tali™, image-based cytometer analysis of isolated chicken thrombocyte
suspension. Isolated thrombocyte suspension was analyzed using, Tali™ at CLIF,
Clemson University, Clemson, SC. The cell suspension was incubated with Alexa Fluor®
594 labeled monoclonal mouse anti-chicken CD41/61. The analysis shows that 96% of
the cells are positive for thrombocyte specific CD41/61. There were no green fluorescent
labeled cells in this experiment.
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Figure 2.4: Flow cytometric analysis of CD41/61 labeled cells. The histograms shows
surface expression of thrombocyte specific CD41/61 labeled with Alexa Fluor® 488 (red)
compared to cells labeled with only Alexa Fluor® 488 (negative control, blue). The top
panel shows histogram of control cells that were not stimulated and the bottom panel
shows histograms of cells stimulated for 1 hr with 1 µg/mL of lipopolysaccharide (LPS)
and 400 µg/mL of polyinosinic-polycytidylic acid [Poly (I:C)].

51

2.3.2

Expression of MHC Class II
To detect presence of the MHC II on the surface of chicken thrombocytes, we

quantified the percentage of the chicken thrombocyte population expressing MHC II
through cell cytometry analysis (Fig. 2.5A). We also examined percentage of the
MQ.NCSU macrophage cells expressing MHC II (Fig 2.5B). Upon analysis, percent of
thrombocytes and MQ.NCSU macrophages expressing MHC II appears to be very similar
(Table 2.2). It is extremely interesting to find thrombocytes expressing MHC II which is
exclusively limited to true antigen presenting cells (APCs). As an additional observation,
treatment of both thrombocytes and macrophages with LPS and Poly (I:C) does not
change dramatically the percentages of cell expressing MHC II (Table 2.2).

2.3.3

Expression of Co-Stimulatory Molecules
Chicken thrombocytes express co-stimulatory molecules CD40, CD80 and CD86

(Fig. 2.6-2.8). We reconfirm the reported presence of these co-stimulatory molecules on
MQ.NCSU cells (Fig. 2.6-2.8). Nearly all thrombocytes express CD40 while roughly half
of the macrophages were found to be positively identified with this important receptor for
T-cell bearing CD40 ligand (CD40L, Table 2.2). Neither LPS nor Poly (I:C) significantly
affect the expression of any of the co-stimulatory molecules on either cell type (Table
2.2).
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Figure 2.5: Flow cytometric analysis of thrombocytes and MQ.NCSU macrophage
cell line with mouse anti-chicken MHC II. Surface expression pattern of MHC II on
chicken thrombocyte (A) and MQ.NCSU cells (B) on 1 hr control (not stimulated), 1
µg/mL of lipopolysaccharide (LPS) and 400 µg/mL of polyinosinic-polycytidylic acid
[Poly (I:C)] stimulated cells (blue= negative control and red=Alexa 488 labeled MHC II).
On average 93% of the thrombocyte and 98% of the MQ.NCSU macrophage population
express MHC II.
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Table 2.2: Percentages of chicken thrombocytes and MQ.NCSU cells positive for
MHC class II, CD40, 80 and 86 identified by specific antibody labeling detected
through flow cytometric analysis. Surface expression of these molecules were
examined on cells that were stimulated with 1 µg/mL of lipopolysaccharide (LPS), 400
µg/mL of polyinosinic-polycytidylic acid [Poly (I:C)] for an hour and control (no
stimulation) cells.
Antibody % Positive Thrombocytes

% Positive MQ.NCSU cells

Control

LPS

Poly (I:C) Control

LPS

Poly (I:C)

MHC II

84.5

99.0

96.1

98.6

97.9

99.2

CD40

91.9

92.1

90.1

49.0

45.6

56.6

CD80

99.7

99.7

99.8

99.3

99.3

99.2

CD86

99.2

94.3

98.8

91.9

90.6

89.0
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Control

LPS

Poly (I:C)

Figure 2.6: Flow cytometric analysis of thrombocytes and MQ.NCSU macrophage
cell line with mouse anti-chicken CD40. Surface expression of CD40 on chicken
thrombocyte (A) and MQ.NCSU cells (B) on 1 hr control (no stimulation), 1 µg/mL of
lipopolysaccharide (LPS) and 400 µg/mL of polyinosinic-polycytidylic acid [Poly (I:C)]
stimulated cells (blue= negative control and red=Alexa 488 labeled CD40). Although the
curves appear to be similar, on average 91% of the thrombocyte and 50% of the
MQ.NCSU macrophage population express CD40. The shift of the CD40 positive
population compared to the negative population is much lower than that observed for
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MHC II and other co-stimulatory molecules. Mean intensity unit comparison reveals the
reason for the smaller shift to the right. It indicates that the number of CD40 receptors
present per cell is lower on both thrombocytes and MQ.NCSU macrophages compared to
MHC II, CD80 and CD86.
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Control

LPS

Poly (I:C)

Figure 2.7: Flow cytometric analysis of thrombocytes and MQ.NCSU macrophage
cell line with mouse anti-chicken CD80. Surface expression of CD80 on chicken
thrombocyte (A) and MQ.NCSU cells (B) on 1 hr control, 1 µg/mL of lipopolysaccharide
(LPS) and 400 µg/mL of polyinosinic-polycytidylic acid [Poly (I:C)] stimulated cells
(blue= negative control and red=Alexa 488 labeled CD80). Thrombocytes and
MQ.NCSU macrophages both were over 99% positive for CD80, but the average mean
intensity value for thrombocyte was 175 while MQ.NCSU macrophages were 35. This
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indicates that there are less CD80 receptors per MQ.NCSU macrophage than
thrombocytes.
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Control

LPS

Poly (I:C)

Figure 2.8: Flow cytometric analysis of thrombocytes and MQ.NCSU macrophage
cell line with mouse anti-chicken CD86. Surface expression of CD86 on chicken
thrombocyte (A) and MQ.NCSU cells (B) on 1hr control (no stimulation), 1 µg/mL of
lipopolysaccharide (LPS) and 400 µg/mL of polyinosinic-polycytidylic acid [Poly (I:C)]
stimulated cells (blue= negative control and red=Alexa 488 labeled CD86).
Thrombocytes were 97% and MQ.NCSU macrophages 91% positive for CD80, but the
average mean intensity value indicate that there was twice as much CD86 receptors on
MQ.NCSU than thrombocytes.
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2.3.4

Expression of TLRs
Previous work from our laboratory has shown that chicken thrombocytes respond to

LPS stimulation which takes place through TLR4 to activate MAP kinase and NF-κB
ptahways (Scott and Owens, 2008). We wanted to further verify if thrombocytes express
other TLRs and if those TLRs can be stimulated with other TLR ligands such as Poly
(I:C) (TLR3 ligand). A preliminary assessment of the gene expression in thrombocytes
was done through a RNA microarray at the University of Delaware (C. Keeler) for Tolllike receptor pathways genes. Examples of some of the TLR specific up-regulated genes
are shown in Table 2.3. These results were used to guide our decisions on “likelysuspect” TLRs to examine. We show that chicken thrombocytes express transcripts of
TLR2, TLR3, TLR4, and TLR7 (Fig. 2.9). One hour LPS and Poly (I:C) stimulation
appears to increase expression of these TLRs indicating a generalize, non-specific
expression in thrombocytes. Antibodies for chicken TLRs are not available so we have
not been able to report a specific identification of the receptor via cell surface expression,
although thrombocytes do respond to TLR ligands and gene expression is detectable.

2.4 Discussion
In order to perform experiments and study the characteristics of chicken
thrombocytes, it was essential for us to have an enriched population of thrombocytes.
Chicken thrombocytes can be identified with monoclonal antibodies such as 23C6
(Viertlboeck and Göbel, 2007) and K1 (Kaspers et al., 1993), that recognize the intact
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Table 2.3: RNA microarray analysis of Toll-like receptor (TLR) pathway specific
molecules by using control and 1hr lipopolysaccharide (1 µg/mL) stimulation of
chicken thrombocytes.
Gene

Fold Change from Control

Interleukin 1β (IL1-β, IL1B)

5.756

Inducible nitric oxide synthase

5.744

TLR5

4.266

Major histocompatibility complex class I 2.868
glycoprotein
Nuclear factor kappa-light-chain-enhancer 2.683
of activated B cells p50 subunit
C-fos proto-oncogene

2.669

Interleukin 6

2.385

V-jun

1.947

TLR3

1.737
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Figure 2.9: Relative quantification in terms of fold expression of Toll-like receptors
(TLRs) 2, 3, 4, and 7. Fold expression values are calculated relative to glyceraldehyde 3phosphate dehydrogenase (GAPDH, housekeeping gene) according to Pfaffl (2001) using
the cycle number obtained from the quantitative real-time polymerase chain reaction and
amplification efficiencies of target and housekeeping gene. One hour stimulation with
lipopolysaccaride (LPS, 1 µg/mL) and polyinosinic-polycytidylic acid [Poly (I:C), 400
µg/mL) appears to increase expression of these TLRs compared GAPDH.
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complex formed between CD41 and CD61 (αV and β3 integrin) and an unidentified
epitope, respectively, on the surface of chicken thrombocytes. Here we used mouse antichicken CD41/61, clone 11C3 that recognizes the chicken integrin complex which is a
heterodimeric cell surface protein. We have consistently observed enriched populations
of thrombocytes using our isolation procedure (Fig. 2.2-2.4). It was reassuring to see that
stimulation with LPS or Poly (I:C) did not change the surface expression of this integrin
complex (Fig. 2.4) that could have potentially changed through TLR activation and led to
an altered ability for thrombocytes to bind to specific integrin ligands.
In our search to find relevant immune molecules expressed on the surface of
chicken thrombocytes, we found expression of MHC II and co-stimulatory molecules
CD40, CD80 and CD86 on the majority of thrombocytes. Expression of MHC II is a
unique finding for chicken thrombocytes since mammalian platelets are devoid of MHC
class II molecules (Semple, 2011). Generally, dendritic cells (DCs, professional APCs)
express both class I and class II MHC molecules while macrophages and B cells must be
activated to express class II. In our studies, we found chicken thrombocytes to express
class II MHC even in the absence of cellular stimulation. Interestingly, treatment of
thrombocytes with TLR ligands did not change the expression profile for neither
thrombocytes nor MQ.NCSU macrophage cells. Although it has been previously reported
that thrombocytes express transcripts for MHC II and the transcripts for MHC II were
significantly up-regulated in response to LPS and CpG ODN (Paul et al., 2012), we did
not observe a change in expression of MHC II molecules on chicken thrombocytes when
stimulated with LPS or Poly (I:C) (Table 2.2).
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We have also observed expression of co-stimulatory molecules CD40, CD80 and
CD86 on chicken thrombocytes and MQ.NCSU macrophages. Although the percent
positive cells for these receptors were similar (Table 2.2), the actual number of receptors
per cell indicated by mean intensity values were often very different. For example,
thrombocytes and MQ.NCSU macrophages both were over 99% positive for CD80, but
the average mean intensity value for thrombocyte was 175 while MQ.NCSU
macrophages were 35. Based on comparison of mean fluorescence intensity, expression
of CD40 per cell appeared to be lower on thrombocytes and MQ.NCSU macrophages
when compared to CD80 and CD86. Presence of CD40 on primary chicken macrophage
and the chicken HD11 macrophage cell line has been previously shown by Chen et al.
(2010). Interestingly, the distribution of fluorescence intensity is tighter in the
macrophage cell line compared to primary macrophages (Chen et al., 2010), and similar
to what we observe for the MQ.NCSU macrophage cell line.
DCs and most B-cell lineage also express CD40 that binds to complementary
ligand, CD154 (CD40L) on T cells (Kindt et al., 2007). The interaction between
CD40/CD154 can influence cytokine production (such as IL-12). The cytokine IL-12
expressed by APCs can influence T-cell behavior and drive naïve T-cells to differentiate
into T-helper type 1 (TH1) cells. The CD40/CD40 ligand (CD154) interaction also
influences B-cell growth, differentiation and isotype switching. Thus, CD40 plays a
critical role in regulation of cell-mediated immunity as well as antibody-mediated
immunity.
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Our observation shows constitutive expression of CD80 and CD86 on chicken
thrombocytes. The number of receptors for CD80 appears to be higher than that of CD86
per thrombocyte, while number of receptors for CD86 appears to be higher than that of
CD80 per MQ.NCSU macrophage. DCs known as major APCs constitutively express
CD80 and CD86.. DCs are the most important link between innate and adaptive
immunity since they are thought to be the only cell capable of activating naïve T-cells
sufficiently for induction of a productive cellular immune response. Following antigenic
stimulation, DCs mature by increasing their surface expression of MHC class II and Tcell co-stimulatory molecules.
We examined gene expression of several TLRs on chicken thrombocytes.
Expression of different chicken TLRs have been studied by Iqbal et al. (2005) in a wide
range of isolated chicken immune cell types (such as blood monocyte derived
macrophages, heterophils, B cells, and different populations of T-cell subsets) and
cultured cells (such as the DT40 cell line, which is derived from an avian leukosis virustransformed pre-B-cell, and the HD11 cell line that is a retrovirally transformed
macrophage-like cell line). According to Iqbal et al. (2005), TLR1/6/10, TLR3, TLR4
and TLR5 specific RT-PCR products were detected in all immune cell populations
although the level of expression was different for the different cell subset. Chicken TLR2
type 2 mRNA was detected with most cell subsets and chTLR2 type 1 was expressed on a
more restricted subset of cells (heterophils and specific T-cell subsets). HD11 chicken
macrophage cells also express mRNA for chicken TLR15 and TLR21 (Ciraci and
Lamont, 2011).
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Since our group had already demonstrated that expression of the TLR4 transcript is
up-regulated when chicken thrombocytes are stimulated with a bacterial TLR ligand
(LPS) (Scott and Owens, 2008), we next verified expression of TLR2, TLR3 and TLR7.
We also examined if 1 hr LPS or Poly (I:C) stimulation can change the expression pattern
of these TLRs. Poly (I:C) is a synthetic analog of double-stranded RNA (dsRNA), a
molecular pattern associated with viral infection. Poly (I:C) is recognized by TLR3
inducing the activation of NF-kB and the production of cytokines. Although we have
detected transcripts for TLR3 in chicken thrombocytes, there appears to be no significant
change in the expression of TLR3 due to stimulation with Poly (I:C) (Fig. 2.4).
Chicken thrombocytes constitutively express transcripts for different TLRs which is
crucial for the innate immune response. This chapter also provides evidence that
thrombocytes could be non-professional APCs and be involved in adaptive immunity.
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CHAPTER III

BACTERIAL AND VIRAL INDUCTION OF CHICKEN THROMBOCYTE
IMMUNE RESPONSES.

3.1 Introduction
The role of platelets as mediators and effector inflammatory cells has been a focus of
research in the past few decades (Capron et al., 1987; Page, 1989; Herd and Page, 1994;
Klinger, 1997). As inflammatory cells, activated platelets express receptors for adhesive
proteins, different cytokines and other mediators that make direct contact with endothelial
cells, granulocytes, monocytes and lymphocytes to either stimulate or inhibit functions of
other cellular partners in inflammation (Bazzoni et al., 1991; Klinger and Jelkmann,
2002). Platelets also contain cytoplasmic granules that store a vast array of bioreactive
molecules, which play an integral part in inflammation (George, 2000; Elzey et al., 2005;
Semple et al., 2011). With the discovery of functional CD40 ligand (CD154) expression
(Hen et al., 1998; Martinson et al., 2004; Chakrabarti et al., 2005), platelets extend
potential modulatory capacity from innate immunity to adaptive immunity.
Since enucleated platelets have such a crucial role in different aspects of the immune
response, nucleated thrombocytes might also have a significant role in avian immune
responses. Chicken thrombocytes have been shown to release β-thromboglobulin
(Wachowicz and Krajewski, 1981), thrombocyte-derived growth factors (Horiuchi et al.,
1990), lysosomal compounds (Carlson et al., 1968; Daimon and Uchida, 1982),
chemotactic factors (Lam, 2002), platelet-derived growth factor-A and -B chains
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(Horiuchi et al., 2001; Horiuchi et al., 2002) and some of the enzymes from the
arachidonic acid cascade [cyclooxygenase-2 (COX-2), and prostaglandin D2 (PGD2),
PGE2, thromboxane A2 synthases and leukotriene B4] (Scott and Owens, 2008;
Hitchcock, 2009; Jha et al., 2005). Our lab has demonstrated that chicken thrombocytes
respond to lipopolysaccharide (LPS) (Ferdous et al., 2008; Scott and Owens, 2008). This
LPS stimulation takes place through Toll-like receptor (TLR) 4 and mitogen-activated
protein (MAP) kinase (ERK, MEK1 and p38 MAPK) and nuclear factor-κ light-chainenhancer of activated B cells (NF-κB) pathways (Scott and Owens, 2008). Thrombocytes
also express transcripts for TLRs 2, 3, 4, 7 (previous chapter) and 21 (Paul et al., 2012).
Activation of the TLR4 pathway results in gene expression of pro-inflammatory
cytokines interleukin (IL)-6, IL-1β, IL-8, and IL-12 (Scott and Owens, 2008; Ferdous et
al., 2008; Hitchcock, 2009). According to another group of researchers, thrombocytes
constitutively express transcripts for both pro- and anti-inflammatory cytokines for antiviral responses and antigen presentation (Paul et al., 2012). Other recent studies, in the
case of H5N1 Avian Influenza, virus replicated to a high titer in chicken thrombocytes
and caused up-regulation of TLR3 and several cell adhesion molecules (Schat et al.,
2012).
Here, we have examined inflammatory responses when thrombocytes are stimulated
in vitro and in vivo. For the in vitro study, chicken thrombocytes were stimulated with
bacterial ligands; LPS from Gram-negative bacteria (TLR4 ligand), and lipoteichoic acid
(LTA) from Gram-positive bacteria (TLR-2 ligand), and viral ligands; polyinosinicpolycytidylic acid [Poly (I:C)], a synthetic analog of double-stranded RNA (ds RNA)
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(TLR3 ligand), and thymidine homopolymer phosphorothioate ODN [Poly(dT)] a singlestranded RNA product (TLR 7/8 ligand). Chicken thrombocytes express TLRs and
therefore, should participate in immune responses to bacterial and viral TLR ligands. For
the in vivo stimulation, we examined thrombocytes from chickens vaccinated with a
bacterial or viral vaccine. For this experiment, we have used a Gram negative bacterial
vaccine for Salmonella enteritidis and a combination of dsDNA viral vaccine for
infectious bursal disease (IBD) and reovirus (REO). It is probable that thrombocytes of
bacterial or viral vaccine immunized chickens are activated and express proinflammatory genes compared to unvaccinated chickens. The rationale behind this
hypothesis is that the vaccines will activate thrombocytes through TLRs and induce gene
expression and production of pro-inflammatory cytokines and mediators.

3.2 Materials and Methods
3.2.1

Chickens and Vaccines
Female Single Comb White Leghorn (SCWL) chickens (between 16-26 weeks

old) were used for this study. The chickens were housed at the Clemson University
Morgan Poultry Center, Clemson, SC, which is an Institutional Animal Care and Use
Committee (IACUC) approved animal facility operating under standard management
practice adhering to the Association for Assessment and Accreditation of Laboratory
Animal Care International criteria. The chickens were vaccinated according to
manufacturer’s protocol with a killed bacterial vaccine for Salmonella enteritidis
(LAYERMUNE® SE, Ceva Biomune, Lenexa, KS) and a killed viral vaccine for IBD and
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reovirus (Poulvac Maternavac IBD-REO, Zoetis Marietta, Marietta, GA). As a control,
chickens were injected with sterile phosphate buffer saline (PBS). Blood samples were
collected from vaccinated and unvaccinated chickens on Day 0 before vaccination and on
Day 3, 5 and 7 post-vaccination for blood collection and thrombocyte isolation.

3.2.2

Thrombocyte Isolation and In Vitro Stimulation
Syringes fitted with needles were used to collect 3 mL of whole blood from the

wing vein of each chicken into 0.1 mL volume of 10% ethylene diamine tetra acetic acid
(EDTA) solution. The collected blood samples were stored on ice until brought back to
the laboratory. The thrombocyte isolation protocol has been modified from that used by
Horiuchi et al. (2004). Each blood sample was diluted (1:1) with calcium and magnesium
free Hanks balanced salt solution (HBSS) (Cambrex Bio Sciences Walkersville Inc.,
Walkersville, MD). Diluted blood samples were then layered on a lymphocyte separation
medium (Density 1.077-1.080 g/mL, Mediatech. Inc., Herdon, VA) and centrifuged at
1700 x g for 30 min at 23°C. The resultant band of cells containing the thrombocytes was
collected, washed and resuspended in calcium and magnesium free HBSS. Trypan blue
solution (0.4% w/v in normal saline) was used for quantification of viable cell numbers
on a SPolite® Hemacytometer (Baxter Healthcare, McGaw Park, IL) with the aid of an
upright light microscope.
The isolated thrombocytes (1 x 107 in 1 mL) were incubated with 1 μg/mL of ultra
pure LPS from Salmonella minnesota, 400 µg/mL of purified LTA from Staphylococcus
aureus, 400 µg/mL of Poly (I:C) and 50 µM of Poly (dT) (InvivoGen, San Diego, CA).
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The cell suspension and TLR ligands were incubated in sterile 1.5 mL microcentrifuge
tubes on a rocking platform (VWR, Suwanee, GA) at 41°C for 10 and 60 min.

3.2.3

MQ.NCSU Culture and Stimulation
The MQ.NCSU cell line was a generous donation from Dr. Matthew Koci’s

laboratory (NCSU Prestage Department of Poultry Science, North Carolina State
University, Raleigh, NC). These cells were cultured at 41°C and 5% CO2 with LM Hahn
medium made with a combination of Lebovitz A medium (Sigma-Aldrich, St Louis, MO)
and McCoy’s 5a medium (Invitrogen Life Technologies), tryptose phosphate broth
(Sigma Aldrich, St Louis, MO), bovine fetal serum (HyClone®, Logan, Utah), chicken
serum (Sigma-Aldrich, St Louis, MO), glutamine, sodium pyruvate (CellGro, Mediatech
Inc, Manassas, VA), 2-mercaptoethanol (Sigma-Aldrich, St Louis, MO), and a mixture of
penicillin, streptomycin, and fungizone (Lonza Walkersville Inc., Walkersville,
MD)(Qureshi et al., 1990). The MQ.NCSU macrophages (1 x 107 in 1 mL) were
incubated with 1 μg/mL of LPS, 400 µg/mL of LTA, 400 µg/mL of Poly (I:C) and 50
µM of

Poly (dT) (InvivoGen, San Diego, CA) as described above for in vitro

thrombocyte stimulation.

3.2.4

RNA Isolation and Quantification
For RNA isolation after thrombocyte stimulation, cells were centrifuged at 5000 x

g for 2 min to pellet. The pellets were stored in 100 μL of RNAlater (Qiagen Inc.,
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Valencia, CA), a RNA stabilizing solution. After 24 hr at 4°C in RNAlater, the cells were
centrifuged again to remove the supernatant. The cells can be stored at this point at -20°C
for use later if not used immediately. The RNeasy Kit (Qiagen Inc., Valencia, CA) was
used according to the manufacturer’s protocol to isolate the total RNA from these
samples. The RNA samples were treated with an on-column DNase, RNase-free DNase
Set (Qiagen Inc., Valencia, CA) to remove any possible contamination from chicken
genomic DNA. Isolated RNA samples were quantified using a Nano Drop 1000
Spectrophotometer (Thermo Scientific, Waltham, MA).

3.2.5

Quantitative Real Time Polymerase Chain Reaction (qRT-PCR)
Quantitative RT-PCR was performed using a QuantiTech SYBR Green RT-PCR

Kit (Qiagen Inc., Valencia, CA) and an Eppendorf Mastercycler ep realplex (Eppendorf
North America, Westbury, NY). Primers used for GAPDH, IL-6 and iNOS amplification
are listed in Table 3.1. The RT-PCR mixture consisted of 0.20 μL QuantitTect RT Mix,
10 μL 2× QuantitTect SYBR Green RT-PCR Master Mix, 0.4μL of 0.5 μM of each
specific primer listed in Table 3.1, 8 μL of 1 ng/μL template RNA, and 1 μL of RNasefree water to make the final reaction volume of 20 μL. The cycling profile for all the
reactions was 1 cycle of 50°C for 30 min 95°C for 15 min, and 40 cycles of 94°C for 15
s, 57°C for 20 s, and 72°C for 20 s.
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Table 3.1: Quantitative real-time polymerase chain reaction primer sets for
messenger

RNA

of

glyceraldehyde

3-phosphate

dehydrogenase

(GAPDH,

housekeeping gene), interleukin-6 inducible nitric oxide synthase.
Target

Accession

RNA

No.

GAPDH

NM_204305

Primer Sequence (5’-3’)

Efficiency
(E)

F: ATGCCATCACAGCCACACAGAAGA

0.98

R: ATGCCATCACAGCCACACAGAAGA
IL-6

AJ30954

F: ATGTGCAAGAAGTTCACCGTGTGC

0.91

R: TTCCAGGTAGGTCTGAAAGGCGAA
iNOS

NM_204961.1 F: ATGGGAACAGAGATTGGAGTGCGA
R: TACAACAGCTCGGTCCTTCCACAA
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1.01

3.2.6 NO Assay
The Griess Reagent System (Promega Corporation, Madison, WI) was used to
investigate nitric oxide (NO) formation by measuring nitrite, which is one of two
primary, stable and nonvolatile breakdown products of NO. A Nitrite Standard reference
curve was prepared for each assay for accurate quantitation of experimental samples
according to the manufacture’s protocol. The nitrite concentration of the reference curve
ranged from 0-100 μM. The assay was performed as suggested in the the manufacture’s
protocol. Briefly, 50 μL of each experimental sample (supernatant from control and
stimulated chicken thrombocytes and MQ.NCSU cells) were added to wells of a 96-well
plate in triplicate. Using a multichannel pipettor, 50 μL of the Sulfanilamide Solution was
then added to all experimental samples and wells containing the dilution series for the
Nitrite Standard reference curve. Following 10 min incubation at room temperature in
dark, 50 μL of the N-1-napthylethylenediamine dihydrochloride (NED) solution was
added to all wells. A purple/magenta color forms immediately after addition of the NED
solution. After another 10 min of incubation at room in dark, plates were read on a Power
Wave X Microplate Scanning Spectrophotometer (Bio-Tek® Instruments, Inc., Winooski,
VT) at 520 nm.

3.2.7

B9 Cell Bioassay
The bioactivity of IL-6 in supernatants of control and stimulated chicken

thrombocytes and MQ.NCSU cells was assessed according to their ability to promote
growth of the IL-6-dependent murine hybridoma B9 cells (Helle et al., 1991; Rath et al.,
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1995). Controls included recombinant chicken IL-6 (AbD Serotec, Raleigh, NC), ligand
spiked samples and B9 cells only with RPMI-1640 medium. Recovered cells were
adjusted to 1 × 105 cells/mL with IL-6-free cell culture medium following a viability
determination by trypan blue exclusion. Aliquots of 100 μl of different IL-6 sources and
100 μL of B9 cell suspension (1 × 104 cells) were added to appropriate wells. The plate
containing the cells were then placed in a humidified 5% CO2 incubator at 37°C for 92
hr. Then, 50 μL of MTT (5 mg/mL, tetrazolium salt, 3-(4, 5-dimethylthiazol-2-yl)-2, 5diphenyl-tetrazolium bromide, Sigma Chemical Co., St. Louis) were added to each well
and incubated again for 4 hr in the incubator. At conclusion of incubation, the supernatant
from each well was removed and 150 µL of DMSO (Dimethylsulfoxide, EMD Chemical
Inc., Darmstadt, Germany) was added to dissolve dye crystals. Plates were read on a
Power Wave X Microplate Scanning Spectrophotometer (Bio-Tek® Instruments, Inc.,
Winooski, VT) at 570 and 650 nm.

3.2.8

Statistical Analysis

A series of complete random designed experiments with a 2 × 5 factorial arrangement
of treatments was used where treatments were 2 response times (10 and 60 min) and 5
TLR ligands [control (or no ligand), LPS, LTA, Poly (I:C) and Poly (dT)] for the in vitro
study. For the in vivo vaccine study, a complete random design was used where the
treatments were vaccine (Layermune SE or Poulvac Maternavac IBD-REO) and no
vaccine (PBS). Analysis of variance was performed with the General Linear Model
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procedure of SAS 9.1 (SAS Manual 2000), and hypothesis testing is conducted using α =
0.05.

3.3 Results
3.3.1. Interleukin-6 (IL-6) Gene Expression and Release
In vitro treatment of thrombocytes with various TLR ligands demonstrates a
definite bacterial effect while no viral effect on gene expression of IL-6. Among the two
bacterial TLR ligands used, a dramatic LPS effect was observed at 60 min while a LTA
effect is less dramatic but apparent at both 10 and 60 min (Fig. 3.1). However, both viral
TLR ligands Poly (I:C) and Poly (dT) did not induce detectable IL-6 gene expression by
60 min (Fig. 3.1). Immunizations with Layermune SE and Poulvac Maternavac IBD-REO
do not induce an effect on IL-6 gene expression (Fig. 3.2 and 3.3) in the time frame post
immunizations.
In order to examine if there was any difference in release of IL-6 at the protein
level, the B9 cell bioassay was performed with culture supernatants. IL-6 activity in
supernatants was observed for 60 min LPS treated thrombocytes (Fig. 3.4). Other ligands
did not affect thrombocyte release of IL-6 (Fig. 3.4) compared to control. A comparison
study with the MQ.NCSU macrophage cell line did not reveal induced release of IL-6
even at 6 and 24 hours of treatment (Fig. 3.5). Thrombocytes are extremely reactive to
LPS, but not other ligands with regard to IL-6, and thus, provide a ready source for IL-6
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Figure 3.1: Relative fold expression of interleukin-6 (IL-6) in control and stimulated
chicken thrombocytes. Thrombocytes were stimulated for 10 min and 60 min with
lipopolysaccaride (LPS, 1 µg/mL), lipoteichoic acid (LTA, 400 µg/mL), polyinosinicpolycytidylic acid [Poly (I:C), 400 µg/mL) and homopolymer phosphorothioate ODN
[Poly(dT), 50 µM. Fold expression values are calculated relative to glyceraldehyde 3phosphate dehydrogenase (GAPDH, housekeeping gene) according to Pfaffl (2001) using
the cycle number obtained from the quantitative real-time polymerase chain reaction and
amplification efficiencies of target (IL-6) and housekeeping gene (GAPDH). Only the
LPS stimulation at 60 min showed significant increase of IL-6. Error bars show ± SEM
with 6 samples.

*

Statistically significant difference when compared against respective

control (p≤0.05).
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Figure 3.2: Relative fold expression of interleukin-6 (IL-6) in control and
Layermune SE vaccinated chicken thrombocytes. The chickens were vaccinated
according to manufacturer’s protocol with a killed bacterial vaccine for Salmonella
enteritidis (LAYERMUNE® SE, Ceva Biomune, Lenexa, KS) and as control, chickens
were injected with sterile phosphate buffer saline (PBS). Quantitative real-time
polymerase chain reaction (qRT-PCR) was performed using thrombocytes isolated from
blood samples collected from vaccinated and unvaccinated chickens on Day 0 before
vaccination and on Day 3, 5 and 7 post-vaccination. Fold expression values are calculated
relative to glyceraldehyde 3-phosphate dehydrogenase (GAPDH, housekeeping gene)
according to Pfaffl (2001) using the cycle number obtained from the qRT-PCR and
amplification efficiencies of target (IL-6) and housekeeping gene (GAPDH). No
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statistical difference was observed in IL-6 expression in thrombocytes collected from
vaccinated and control chickens. Error bars show ±SEM with 4 samples.
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Figure 3.3: Relative fold expression of interleukin-6 (IL-6) in control and Poulvac
Maternavac vaccinated chicken thrombocytes. The chickens were vaccinated
according to manufacturer’s protocol with a killed viral vaccine for IBD and reovirus
(Poulvac Maternavac IBD-REO, Zoetis Marietta, Marietta, GA) and as control, chickens
were injected with sterile phosphate buffer saline (PBS). Quantitative real-time
polymerase chain reaction (qRT-PCR) was performed using thrombocytes isolated from
blood samples collected from vaccinated and unvaccinated chickens on Day 0 before
vaccination and on Day 3, 5 and 7 post-vaccination. Fold expression values are calculated
relative to glyceraldehyde 3-phosphate dehydrogenase (GAPDH, housekeeping gene)
according to Pfaffl (2001) using the cycle number obtained from the qRT-PCR and
amplification efficiencies of target (IL-6) and housekeeping gene (GAPDH). No
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statistical difference was observed in IL-6 expression in thrombocytes collected from
vaccinated and control chickens. Error bars show ±SEM with 5 samples.
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Figure 3.4: Stimulation index of B9 cell bioassay with supernatants from control
and stimulated chicken thrombocytes. The bioactivity of IL-6 in supernatants of
control and stimulated chicken thrombocytes was assessed according to their ability to
promote growth of the IL-6-dependent murine hybridoma B9 cells Thrombocytes were
cultured with lipopolysaccaride (LPS, 1 µg/mL), lipoteichoic acid (LTA, 400 µg/mL),
polyinosinic-polycytidylic

acid

[Poly

(I:C),

400

µg/mL)

and

homopolymer

phosphorothioate ODN [Poly(dT), 50 µM for 10 min and 60 min. LPS stimulation for 60
min released enough IL-6 to show a significant increase in stimulation index compare d
to any other ligands at 10 min or 60 min. Error bars show ±SEM with 5 samples.
Statistically significant difference when compared against respective control (p≤0.05).
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*

Figure 3.5: Stimulation index of B9 cell bioassay with supernatants from control
and stimulated MQ.NCSU macrophages. The bioactivity of IL-6 in supernatants of
control and stimulated MQ.NCSU chicken macrophage cells was assessed according to
their ability to promote growth of the IL-6-dependent murine hybridoma B9 cells The
MQ.NCSU chicken macrophage cells were cultured with lipopolysaccaride (LPS, 1
µg/mL), and polyinosinic-polycytidylic acid [Poly (I:C), 400 µg/mL) 10 min, 1 hr, 6hr
and 24hr. The MQ-NCSU macrophage cell line does not show significant increase or
decrease of IL-6 release at 10 min, 1hr, 6hr or 24 hr when stimulated with LPS or Poly
(I:C).
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that can be systemically released and lead to drastic consequences under circumstances of
gram-negative bacterial exposure. This exposure would apparently have to be bloodborne and in excess of the exposure provided through subcutaneous immunization with a
bacterial vaccine that may not have sufficient TLR ligand (i.e. LPS) concentration to
induce in vivo induction of thrombocytes.

3.3.7

Inducible Nitric Oxide Synthases (iNOS) Gene Expression and Nitric Oxide (NO)
Release
In vitro treatment of thrombocytes with TLR ligands did not induce a dramatic

rise in gene expression of iNOS (Fig. 3.6). Ct values for iNOS gene are around midtwenties (Fig. 3.7) whereas the Ct values for the housekeeping gene are around lowtwenties (not shown). Also, there is not much difference in the delta Ct values (Fig. 3.8),
which are the difference in Ct values from the housekeeping gene. Expression of iNOS
appears to be constitutive in thrombocytes. Immunization with Layermune SE and
Poulvac Maternavac IBD-REO do not induce an effect on gene expression of iNOS postvaccination on Day 0, 3, 5 and 7 (Fig. 3.9 and 3.10).
We have also examined nitrite (NO2–) formation by performing the Griess Reagent
Assay that allows spectrophotometric detection of NO2– formed by spontaneous oxidation
of nitric oxide (NO). Interestingly, in vitro treatment of thrombocytes with both viral
TLR ligands Poly (I:C) and Poly (dT) induce significant release of NO into culture
supernatant at both 10 and 60 min (Fig. 3.11). This is an almost instantaneous event as
observed in a preliminary study where NO release was detected in supernatants of
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Figure 3.6: Relative fold expression of inducible nitric oxide synthase (iNOS) in
control and stimulated chicken thrombocytes. Thrombocytes were stimulated for 10
min and 60 min with lipopolysaccaride (LPS, 1 µg/mL), lipoteichoic acid (LTA, 400
µg/mL), polyinosinic-polycytidylic acid [Poly (I:C), 400 µg/mL) and homopolymer
phosphorothioate ODN [Poly(dT), 50 µM. Fold expression values are calculated relative
to glyceraldehyde 3-phosphate dehydrogenase (GAPDH, housekeeping gene) according
to Pfaffl (2001) using the cycle number obtained from the quantitative real-time
polymerase chain reaction and amplification efficiencies of target (iNOS) and
housekeeping gene (GAPDH). No significant changes were observed in gene expression
of iNOS at any time point due to stimulation with any bacterial or viral ligands. Error
bars show ± SEM with 6 samples.
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Figure 3.7: Averge cycle number (Ct values) of inducible nitric oxide synthase
(iNOS) gene expression in control, and stimulated chicken thrombocytes. For
quantitative real-time olymerase chain reaction, the cycle number for each sample at
which the fluorescence crosses the established threshold is referred as the Ct value.
Thrombocytes were stimulated for 10 min and 60 min with lipopolysaccaride (LPS, 1
µg/mL), lipoteichoic acid (LTA, 400 µg/mL), polyinosinic-polycytidylic acid [Poly (I:C),
400 µg/mL) and homopolymer phosphorothioate ODN [Poly(dT), 50 µM. Ct values for
iNOS gene are around mid-twenties whereas the Ct values for the housekeeping gene is
around low-twenties (not shown here). Error bars show ±SEM with 6 samples.
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Figure 3.8: Difference in Ct values of control, and stimulated chicken thrombocytes
for inducible nitri oxide synthase (iNOS) gene. For quantitative real-time olymerase
chain reaction, the cycle number for each sample at which the fluorescence crosses the
established threshold is referred as the Ct value. The delta Ct values are difference in Ct
between the housekeeeping gene, GAPDH and iNOS. The delta Ct values within the
treatment did not change significantly among the different treatments compare to
housekeeping gene. This indicates that iNOS appears to be constitutively expressed in
thrombocytes. Error bars show ±SEM with 6 samples.
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Figure 3.9: Relative fold expression of inducible nitric oxide synthase (iNOS) in
control and Layermune SE vaccinated chicken thrombocytes. The chickens were
vaccinated according to manufacturer’s protocol with a killed bacterial vaccine for
Salmonella enteritidis (LAYERMUNE® SE, Ceva Biomune, Lenexa, KS) and as control,
chickens were injected with sterile phosphate buffer saline (PBS). Quantitative real-time
polymerase chain reaction (qRT-PCR) was performed using thrombocytes isolated from
blood samples collected from vaccinated and unvaccinated chickens on Day 0 before
vaccination and on Day 3, 5 and 7 post-vaccination. Fold expression values are calculated
relative to glyceraldehyde 3-phosphate dehydrogenase (GAPDH, housekeeping gene)
according to Pfaffl (2001) using the cycle number obtained from the qRT-PCR and
amplification efficiencies of target (iNOS) and housekeeping gene (GAPDH). Relative
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fold expression of iNOS in control (no vaccine, PBS injected) and Layermune SE
vaccinated chicken thrombocytes show no significant differences. Error bars show ±SEM
with 4 samples.
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Figure 3.10: Relative fold expression of inducible nitric oxide synthase (iNOS) in
control and Poulvac Maternavac IBD-REO vaccinated chicken thrombocytes. The
chickens were vaccinated according to manufacturer’s protocol with a killed viral vaccine
for IBD and reovirus (Poulvac Maternavac IBD-REO, Zoetis Marietta, Marietta, GA)
and as control, chickens were injected with sterile phosphate buffer saline (PBS).
Quantitative real-time polymerase chain reaction (qRT-PCR) was performed using
thrombocytes isolated from blood samples collected from vaccinated and unvaccinated
chickens on Day 0 before vaccination and on Day 3, 5 and 7 post-vaccination. Fold
expression values are calculated relative to glyceraldehyde 3-phosphate dehydrogenase
(GAPDH, housekeeping gene) according to Pfaffl (2001) using the cycle number
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obtained from the qRT-PCR and amplification efficiencies of target (iNOS) and
housekeeping gene (GAPDH). Relative fold expression of iNOS in control (no vaccine,
PBS injected) and Poluvac Maternavac vaccinated chicken thrombocytes show no
significant differences. Error bars show ±SEM with 5 samples.
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Figure 3.11: Release of nitrite from control and stimulated chicken thrombocytes.
The Griess Reagent System (Promega Corporation, Madison, WI) was used to investigate
nitric oxide formation by measuring nitrite release in thrombocyte culture supernatants.
Thrombocytes were stimulated for 10 min and 60 min with lipopolysaccaride (LPS, 1
µg/mL), lipoteichoic acid (LTA, 400 µg/mL), polyinosinic-polycytidylic acid [Poly (I:C),
400 µg/mL) and homopolymer phosphorothioate ODN [Poly(dT), 50 µM.. Both viral
Toll-like receptor (TLR) ligands Poly (I:C) and Poly (dT) ) induce significant release of
NO into culture supernatant at both 10 and 60 min whereas bacterial TLR ligands LPS
and LTA do not. Error bars show ±SEM with 6 samples.
difference when compared against respective control (p≤0.05).
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*

Statistically significant

Figure 3.12: Release of nitrite from control and stimulated chicken macrophage cell
line. The Griess Reagent System (Promega Corporation, Madison, WI) was used to
investigate nitric oxide (NO) formation by measuring nitrite release in MQ.NCSU
macrophage cell culture supernatants. The MQ.NCSU macrophages were stimulated for
10 min , 60 min, 6hr and 24 hr with lipopolysaccaride (LPS, 1 µg/mL), and polyinosinicpolycytidylic acid [Poly (I:C), 400 µg/mL). The MQ-NCSU cells when stimulated with
LPS released significant NO only after 6 hr whereas Poly (I:C) did not lead to release of
much NO even after 24 hr.
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thrombocytes treated with Poly (I:C) and immediately sampled for NO detection. While
the MQ.NCSU macrophage cells did not respond to TLR ligand treatment with detectable
IL-6 release; LPS, but not Poly (I:C), caused release of NO at 6 and 24 hours of culture
(Fig. 3.12). It is interesting that the macrophages did respond to LPS treatment with the
resultant NO release, while thrombocytes responded to viral ligands and did so in a very
short time of exposure to ligands in culture.

3.4 Discussion
We have determined that chicken thrombocytes express genes for TLRs 2, 3, 4, and 7,
which is evidence that these cells are programmed for recognition of bacterial and viral
ligands that induce TLR pathways to inflammatory products. Here, we have examined
inflammatory responses when thrombocytes are stimulated with bacterial [LPS (TLR4
ligand), and LTA (TLR2 ligand)] and viral [Poly (I:C) (TLR3 ligand), and Poly(dT)
(TLR 7/8 ligand)] ligands. Chicken thrombocytes showed significant increase in
expression of the IL-6 gene by 60 min when stimulated with LPS, which agrees with
previous reports from our laboratory (Scott and Owens, 2008). Conversely, Grampositive ligand (LTA) did not induce very much IL-6 gene expression while the two viral
ligands did not affect gene expression at all. The latter bacterial result was unexpected
(Fig. 3.1) based on responses of chicken heterophils, which are known avian innate
immune cells that have been studied extensively by Kogut’s group. Chicken heterophils
are functionally similar to mammalian neutrophils and these cells constitutively express
several TLRs (Kogut et al., 2005). Bacterial TLR agonists such as LPS, peptidoglycan,
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flagellin and synthetic bacterial lipoprotein, all induce an up-regulation of expression of
mRNA of the pro-inflammatory cytokines IL-1β, IL-6, and IL-8 in heterophils. Viral
ligands Poly (I:C) and the guanosine analog, loxoribine both induce down-regulation of
these cytokine mRNAs in chicken heterophils (Kogut et al., 2005), which makes the
thrombocyte viral responses consistent with that of the heterophil.
Thrombocytes from chickens vaccinated with Layermune SE did not show any
significant difference in expression of IL-6 on Day 0, 3, 5 and 7 (Fig. 3.2). There could
be several reasons for this. The first reason may be that it takes longer for the immune
system to respond to the vaccine as opposed to isolated thrombocytes in cell culture. We
tested the serum antibody titer against Salmonella, which was negative for most of the
samples tested on those days indicating the greater complexity of the entire immune
system to generate a positive antibody titer in the blood. The second reason may be
contact between purified LPS and thrombocytes in vitro is very different from any
bacterial LPS of a vaccine containing killed bacteria. If thrombocytes were collected
from chickens directly exposed to pathogenic bacteria, IL-6 gene expression may look
similar to what we observe for thrombocytes stimulated with LPS in culture.
Thrombocytes from chickens vaccinated with Poulvac Maternavac IBD-REO also did not
show any significant difference in expression of IL-6 which could be also for similar
reasons (Fig. 3.3) or related to the same inability of viral TLR ligands to induce changes
in IL-6 gene expression of in vitro thrombocytes.
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Since mRNA expression for a pro-inflammatory cytokine or an enzyme does not
guarantee the expression of the functional protein, we examined the release of the proinflammatory mediators. The bioactivity of IL-6 in the supernatant of stimulated chicken
thrombocytes was examined using an assay with IL-6-dependent murine hybridoma B9
cells. Results from the B9 assay indicated that by 1 hr, there was a significant amount of
active IL-6 in the supernatants of stimulated chicken thrombocytes (Fig. 3.4). The time
that it took to release the IL-6 from thrombocytes may be dependant on if the protein
needs to be formed or is pre-formed. Based on our preliminary research, IL-6 may be
synthesized upon stimulation with LPS, and, therefore, takes up to an hour to be released.
In the case of the macrophage cell line (MQ-NCSU), we did not observed IL-6
production even after 24 hr (Fig. 3.5). In a reported study, plasma IL-6 has been found to
be elevated at 12 and 24 hr when broiler chicks were administered LPS compared to
control chickens (Xie et al., 2000). After 48 hr, LPS-treated chicken plasma had very
little IL-6 activity, which was comparable with that of saline-treated chickens. Xie et al.
(2000) also found changes in plasma IL-6 activity to have a strong correlation with the
blood heterophil levels at time points after LPS injection.
We have also examined gene expression of inducible nitric oxide synthase (iNOS),
which is involved in the metabolism of L-arginine to L-citrulline and production of NO.
Endotoxins or cytokines such as LPS and interferon (IFN)-γ are classic inducers of iNOS
mRNA and lead to nitric oxide production in chicken phagocytes within hours of
exposure (Hussein and Qureshi, 1997; Quereshi et al., 1994). Ct values for control
chicken thrombocytes suggest a constitutive level of iNOS gene expression (Fig. 3.8 and

98

3.9). Regardless of stimulation with bacterial endotoxins LPS and LTA or synthetic
analogs of viral toxins Poly (I:C) and Poly (dT), we did not observe a ligand effect. There
was also no significant difference seen in iNOS expression in thrombocytes vaccinated
with Layermune SE and Poulvac Maternavac IBD-REO (Fig. 3.9 and 3.10).
However, Hussein and Qureshi (1997) reported that macrophage iNOS expression
peaked between 6 and 12 hr after stimulation with LPS. Although expression of iNOS
has not been directly examined in chicken heterophils, in-direct measure of iNOS activity
has been examined by determination of nitrite release. We detected nitrite release by
chicken thrombocytes exposed to both viral analogs soon after treating the cells in culture
(Fig. 3.11), whereas bacterial ligand did not result in nitrite production. This is different
from what has been reported in the literature where chicken heterophils, monocytes and
macrophages (HD11 cell line) have been shown to produce NO in response to several
killed bacteria and LPS from Salmonella enteritidis (Crippen et al., 2003). Another
difference observed here is that very limited stimulation with Poly (I:C) and Poly (dT)
resulted in significant nitrite production. When we performed a similar study with a
macrophage cell line (MQ-NCSU), we saw LPS stimulation after 6 hr resulted in
significant NO, whereas Poly (I:C) did not release much NO even after 24 hr (Fig. 3.12).
Crippen et al. (2003), have shown it takes 24 hr of LPS stimulation to observe minimal
levels of nitrite production from chicken heterophils. The thrombocyte rapid release of
nitrite observed could be due to pre-packaged presence of nitrite in chicken
thrombocytes, if indeed gene expression of iNOS is constitutive in nature leading to a
steady state of NO production in the cell.
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Chicken thrombocytes demonstrated differential response when stimulated with
bacterial or viral TLR ligands in vitro. The responses observed by thrombocytes are
similar to other avian innate effector cells. Vaccination with recommended doses of
Layermune SE and Poulvac Maternavac vaccine is not sufficient to stimulate chicken
thrombocytes to induce expression of pro-inflammatory mediators.
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CHAPTER IV

CONCLUSIONS AND FUTURE STUDIES

4.1 Conclusions
Chicken thrombocytes are immune cells. These cells are involved in the innate
immune response by producing pro-inflammatory mediators such as IL-6 and NO.
Thrombocytes also express genes for several TLR. However, thrombocytes respond
differentially to bacterial and viral TLR ligands. In vitro treatment of thrombocytes with
various TLR ligands demonstrates a definite bacterial effect while no viral effect on gene
expression of IL-6. Bacterial ligand, LPS stimulation led to release of significant amounts
of active IL-6 in the thrombocyte culture supernatants by 1 hr. In vitro treatment of
thrombocytes with various TLR ligands also indicated constitutive expression of iNOS
gene expression. Although in vitro treatment of thrombocytes with both viral TLR
ligands Poly (I:C) and Poly (dT) induce significant release of NO into culture supernatant
at both 10 and 60 min, no bacterial ligands led to release of NO. In vivo treatment by
vaccination with the recommended doses of Layermune SE (for Salmonella enteritidis)
and Poulvac Maternavac vaccine (for infectious bursal disease and reovirus) was not
sufficient to stimulate chicken thrombocytes to induce expression of pro-inflammatory
mediators.
Chicken thrombocytes are also capable of being involved in the adaptive immune
response. It is extremely interesting to find thrombocytes expressing major MHC II
which is exclusively limited to true APCs. Significant surface expression of MHC II was
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detected in control and TLR ligand stimulated chicken thrombocytes. Moreover, chicken
thrombocytes also express co-stimulatory molecules CD40, CD80 and CD86, which
provides evidence that thrombocytes could be non-professional APCs.

4.2 Future Studies
We need to understand how thrombocytes are involved in immune responses
when exposed to significant challenges by bacterial or viral antigens. We have tried
immunizing chickens with a bacterial (Layermune SE) and viral (Poulvac Maternavac
IBD-REO) vaccines to examine if that would lead to stimulation of chicken thrombocytes
in vivo. We used the recommended dose for vaccination. However, we sampled the
chickens on Day 3, 5 and 7, which may be too early to see significant antibody responses.
We did not observe any difference in gene expression of pro-inflammatory mediators in
the thrombocytes. Future experiments can accommodate for these issues by vaccinating
chickens with a higher dose of antigens and use of alternative sampling times postimmunization.
In a review, Wu and Kaiser (2011) discussed the importance of understanding
both the site and mechanism of antigen presentation in the bird, in order to rationally
design and manipulate viral- or -DNA-vectored vaccines, for example by including host
genes that would target the vaccines to APCs such as DCs. To understand the role of
thrombocytes in antigen presentation, experiments need to be designed to examine the
interaction of thrombocytes with other lymphocytes and APCs. Designing such
experiments will be an elaborate task. In order to study the T-cell-polarizing abilities of
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thrombocytes, naïve CD4+ T-cells need to be isolated or sorted, which can be difficult
due to lack of chicken specific antibodies and reagents. Thrombocytes culture techniques
need to be studied and modified since these cells are usually short-lived in culture.
Thrombocytes will need to be stimulated with antigenic peptides such as LPS and more
detailed cytokine and chemokine gene expression needs to be investigated. For example
12 production leads to T helper cell type 1 (TH1) polarization, while CC-chemokine
ligand 2 (CCL2) favors TH2 polarization.
Here we have shown that chicken thrombocytes express MHC II (Chapter 2).
Expression of MHC II is important as the first signal for stimulation of the T-cell. An
antigen-specific signal is mediated through the T-cell receptor (TCR) triggered by MHC
class-II-associated peptides processed from pathogens after internalization through
specialized PRRs (Kapsenberg, 2003). We have also shown here that thrombocytes
express co-stimulatory molecules CD80 and CD86 (Chapter 2), which are involved in the
second signal. This signal is mainly mediated by triggering of CD28 on the T cell by
CD80 and CD86 that are expressed by APCs like DCs after ligation of PRRs
(Kapsenberg, 2003). We have previously observed that LPS stimulation leads to upregulation of gene expression of IL-12 in chicken thrombocytes (Ferdous et al., 2008)
which can be important for the final polarizing signal for T-cell activation. Thus, chicken
thrombocytes should have the ability to be involved in antigen presentation and activation
of T-cell polarization.
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